Evidence map›Paper›PMID 27081496›Full record

ReviewHuman genome variation2014

Clinical impacts of genomic copy number gains at Xq28.

Toshiyuki Yamamoto, Keiko Shimojima, Shino Shimada, Kenji Yokochi, Shinsaku Yoshitomi, Keiko Yanagihara, Katsumi Imai, Nobuhiko Okamoto

Open access · goldAbstract readReview
In one paragraph

Review in Human genome variation, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 43 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Identification ofJournal of the American Heart Association · 2024
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. TheGenes · 2021
    Review
  12. Article
  13. Genetic Analysis ofFrontiers in neurology · 2020
    Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Toshiyuki YamamotoTokyo Women's Medical University Institute for Integrated Medical Sciences, Tokyo, Japan; Department of Pediatrics, Tokyo Women's Medical University, Tokyo, Japan.ORCID 0000-0002-9484-3505
Keiko ShimojimaTokyo Women's Medical University Institute for Integrated Medical Sciences , Tokyo, Japan.
Shino ShimadaTokyo Women's Medical University Institute for Integrated Medical Sciences, Tokyo, Japan; Department of Pediatrics, Tokyo Women's Medical University, Tokyo, Japan.
Kenji YokochiDepartment of Pediatric Neurology, Mikatahara General Hospital , Hamamatsu, Japan.
Shinsaku YoshitomiNational Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders , Shizuoka, Japan.
Keiko YanagiharaDepartment of Pediatric Neurology, Osaka Medical Center and Research Institute for Maternal and Child Health , Izumi, Japan.
Katsumi ImaiNational Epilepsy Center, Shizuoka Institute of Epilepsy and Neurological Disorders , Shizuoka, Japan.
Nobuhiko OkamotoDepartment of Medical Genetics, Osaka Medical Center and Research Institute for Maternal and Child Health , Izumi, Japan .
Tokyo Women's Medical University · JPNational Epilepsy Center · JPOsaka International Cancer Institute · JPSeirei Mikatabara General Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Duplications of the Xq28 region are the most frequent chromosomal aberrations observed in patients with intellectual disability (ID), especially in males. These duplications occur by variable mechanisms, including interstitial duplications mediated by segmental duplications in this region and terminal duplications (functional disomy) derived from translocation with other chromosomes. The most commonly duplicated region includes methyl CpG-binding protein 2 gene (MECP2), which has a minimal duplicated size of 0.2 Mb. Patients with MECP2 duplications show severe ID, intractable seizures and recurrent infections. Duplications in the telomeric neighboring regions, which include GDP dissociation inhibitor 1 gene (GDI1) and ras-associated protein RAB39B gene (RAB39B), are independently associated with ID, and many segmental duplications located in this region could mediate these frequently observed interstitial duplications. In addition, large duplications, including MECP2 and GDI1, induce hypoplasia of the corpus callosum. Abnormalities observed in the white matter, revealed by brain magnetic resonance imaging, are a common finding in patients with MECP2 duplications. As primary sequence analysis cannot be used to determine the region responsible for chromosomal duplication syndrome, finding this region relies on the collection of genotype-phenotype data from patients.

Identifiers

PMID27081496
PMCPMC4785515
OpenAlexW2328811410

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.